Abliva Ab Stock Total Debt
| ABLI Stock | SEK 0.43 0.01 2.38% |
Abliva AB fundamentals help investors to digest information that contributes to Abliva AB's financial success or failures. It also enables traders to predict the movement of Abliva Stock. The fundamental analysis module provides a way to measure Abliva AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abliva AB stock.
Abliva |
Abliva AB Company Total Debt Analysis
Abliva AB's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Abliva AB Total Debt | 92 K |
Most of Abliva AB's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abliva AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Based on the latest financial disclosure, Abliva AB has a Total Debt of 92 K. This is 100.0% lower than that of the Healthcare sector and 99.97% lower than that of the Biotechnology industry. The total debt for all Sweden stocks is 100.0% higher than that of the company.
Abliva AB is the top company in total debt category among its peers. Total debt of Biotechnology industry is presently estimated at about 3.6 Million. Abliva AB holds roughly 92,000 in total debt claiming about 2.55% of stocks in Biotechnology industry.Abliva Fundamentals
| Return On Equity | -0.8 | |||
| Return On Asset | -0.41 | |||
| Current Valuation | 103.38 M | |||
| Shares Outstanding | 1.06 B | |||
| Shares Owned By Insiders | 7.79 % | |||
| Shares Owned By Institutions | 49.04 % | |||
| Price To Book | 0.97 X | |||
| Price To Sales | 2,681 X | |||
| Revenue | 151 K | |||
| Gross Profit | (103.54 M) | |||
| EBITDA | (120.82 M) | |||
| Net Income | (123.49 M) | |||
| Cash And Equivalents | 47.98 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 92 K | |||
| Current Ratio | 2.76 X | |||
| Book Value Per Share | 0.29 X | |||
| Cash Flow From Operations | (114.08 M) | |||
| Earnings Per Share | (0.31) X | |||
| Target Price | 1.0 | |||
| Beta | 1.17 | |||
| Market Capitalization | 316.92 M | |||
| Total Asset | 58.92 M | |||
| Net Asset | 58.92 M |
About Abliva AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abliva AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abliva AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abliva AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Abliva Stock Analysis
When running Abliva AB's price analysis, check to measure Abliva AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abliva AB is operating at the current time. Most of Abliva AB's value examination focuses on studying past and present price action to predict the probability of Abliva AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abliva AB's price. Additionally, you may evaluate how the addition of Abliva AB to your portfolios can decrease your overall portfolio volatility.